Jeffrey Cohen, MD


Jeffrey Cohen, MD: Ofatumumab's Potential Role in MS Care

April 30, 2020

The neurologist at the Mellen Center for MS Treatment and Research at Cleveland Clinic spoke to the wide variety of clinical benefits observed with ofatumumab treatment and how it fits into the MS care landscape.